Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases

15-Deoxy-Δ 12,14 -prostaglandin J 2 induced neurotoxicity via suppressing phosphoinositide 3-kinase

(2017) Hiromi Koma et al.   NEUROPHARMACOLOGY

15-deoxy-Δ12,14-prostaglandin J2 in neurodegenerative diseases and cancers

(2017) Tatsurou Yagami et al.   Oncotarget

Localization of PPAR isotypes in the adult mouse and human brain

(2016) Anna Warden et al.   Scientific Reports

CRTH2, a prostaglandin D2 receptor, mediates depression-related behavior in mice

(2015) Yusuke Onaka et al.   BEHAVIOURAL BRAIN RESEARCH

Localization of 14-3-3δ/ξ on the neuronal cell surface

(2015) Yasuhiro Yamamoto et al.   EXPERIMENTAL CELL RESEARCH

Possible involvement of 15-deoxy-Δ12,14-prostaglandin J2in the development of leptin resistance

(2015) Toru Hosoi et al.   JOURNAL OF NEUROCHEMISTRY

Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System

(2015) Tatsurou Yagami et al.   MOLECULAR NEUROBIOLOGY

Hydrogen peroxide mediated the neurotoxicity of an antibody against plasmalemmal neuronspecific enolase in primary cortical neurons

(2015) Yasuhiro Yamamoto et al.   NEUROTOXICOLOGY

15d-Prostaglandin J2 Protects Cortical Neurons Against Oxygen–Glucose Deprivation/Reoxygenation Injury: Involvement of Inhibiting Autophagy Through Upregulation of Bcl-2

(2014) Haidong Qin et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth

(2014) H.-E. Hsia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Role of Secretory Phospholipase A2 in the Central Nervous System and Neurological Diseases

(2013) Tatsurou Yagami et al.   MOLECULAR NEUROBIOLOGY

15-Deoxy-∆12,14-PGJ2, by Activating Peroxisome Proliferator-Activated Receptor-Gamma, Suppresses p22phox Transcription to Protect Brain Endothelial Cells Against Hypoxia-Induced Apoptosis

(2013) Jui-Sheng Wu et al.   MOLECULAR NEUROBIOLOGY

Leukotriene receptor antagonists, LY293111 and ONO-1078, protect neurons from the sPLA2-IB-induced neuronal cell death independently of blocking their receptors

(2013) Tatsurou Yagami et al.   NEUROCHEMISTRY INTERNATIONAL

Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites

(2013) Hao Liu et al.   NEUROTOXICOLOGY

Thiazolidinediones Promote Axonal Growth through the Activation of the JNK Pathway

(2013) Rodrigo A. Quintanilla et al.   PLoS One

Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2

(2013) Simone Marcone et al.   PROTEOMICS

COX-2 in the neurodegenerative process of Parkinson's disease

(2012) Peter Teismann   BIOFACTORS

15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways

(2011) Yasuhiro Yamamoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma

(2011) Megumi Fujita et al.   CANCER LETTERS

Proteomic Identification of Protein Targets for 15-Deoxy-Δ12,14-Prostaglandin J2 in Neuronal Plasma Membrane

(2011) Yasuhiro Yamamoto et al.   PLoS One

15d-Prostaglandin J2 Enhancement of Nerve Growth Factor–Induced Neurite Outgrowth Is Blocked by the Chemoattractant Receptor– Homologous Molecule Expressed on T-Helper Type 2 Cells (CRTH2) Antagonist CAY10471 in PC12 Cells

(2010) Michiyoshi Hatanaka et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

15-Deoxy- 12,14-Prostaglandin J2 Biphasically Regulates the Proliferation of Mouse Hippocampal Neural Progenitor Cells by Modulating the Redox State

(2010) T. Katura et al.   MOLECULAR PHARMACOLOGY

Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury

(2010) Hao Liu et al.   NEUROBIOLOGY OF DISEASE

15-Deoxi-Δ12,14-prostaglandin J2 is a tubulin-binding agent that destabilizes microtubules and induces mitotic arrest

(2009) Claudia Cocca et al.   BIOCHEMICAL PHARMACOLOGY

Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells

(2009) Lisette T. Arnaud et al.   JOURNAL OF NEUROCHEMISTRY

Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice

(2009) Sha-Ron Pierre et al.   Journal of Neuroinflammation

The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance

(2009) Robert Meller   NEUROSCIENTIST

PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells

(2008) W Chearwae et al.   BRITISH JOURNAL OF CANCER

The ubiquitin-proteasome system in Alzheimer's disease

(2008) Salvatore Oddo   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Transient Receptor Potential A1 Is a Sensory Receptor for Multiple Products of Oxidative Stress

(2008) D. A. Andersson et al.   JOURNAL OF NEUROSCIENCE

The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development

(2008) Deborah K. Morrison   TRENDS IN CELL BIOLOGY

15-Deoxy-Δ12,14-prostaglandin J2: An Electrophilic Trigger of Cellular Responses

(2007) Koji Uchida et al.   CHEMICAL RESEARCH IN TOXICOLOGY